At the time of writing, Lilly(Eli) & Co [LLY] stock is trading at $701.23, up 2.45%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LLY shares have gain 12.08% over the last week, with a monthly amount drifted -7.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lilly(Eli) & Co [NYSE: LLY] stock has seen the most recent analyst activity on August 07, 2025, when Leerink Partners downgraded its rating to a Market Perform but kept the price target unchanged to $715 for it. Previously, Erste Group downgraded its rating to Hold on June 05, 2025. On April 28, 2025, downgrade downgraded it’s rating to Reduce and revised its price target to $700 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $975 on April 22, 2025. Wolfe Research started tracking with a Outperform rating for this stock on November 15, 2024, and assigned it a price target of $1000. In a note dated October 17, 2024, Bernstein initiated an Outperform rating and provided a target price of $1100 on this stock.
For the past year, the stock price of Lilly(Eli) & Co fluctuated between $623.78 and $972.53. Currently, Wall Street analysts expect the stock to reach $856 within the next 12 months. Lilly(Eli) & Co [NYSE: LLY] shares were valued at $701.23 at the most recent close of the market. An investor can expect a potential return of 22.07% based on the average LLY price forecast.
Analyzing the LLY fundamentals
According to Lilly(Eli) & Co [NYSE:LLY], the company’s sales were 53.26B for trailing twelve months, which represents an 37.64% jump. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.43%, Pretax Profit Margin comes in at 0.32%, and Net Profit Margin reading is 0.26%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.88 and Total Capital is 0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 689.09 points at the first support level, and at 676.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 710.08, and for the 2nd resistance point, it is at 718.93.
Ratios To Look Out For
It is important to note that Lilly(Eli) & Co [NYSE:LLY] has a current ratio of 1.28. Further, the Quick Ratio stands at 1.00, while the Cash Ratio is 0.09. Considering the valuation of this stock, the price to sales ratio is 12.46, the price to book ratio is 36.34 and price to earnings (TTM) ratio is 46.50.
Transactions by insiders
Recent insider trading involved Montarce Lucas, EVP & CFO, that happened on Aug 15 ’25 when 715.0 shares were purchased. Director, Alvarez Ralph completed a deal on Aug 13 ’25 to buy 758.0 shares. Meanwhile, EVP & Pres., Lilly Oncology Van Naarden Jacob bought 1000.0 shares on Aug 13 ’25.
